These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12482393)

  • 41. Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus.
    Lakshmi MJD; Jaisankar TJ; Rajappa M; Thappa DM; Chandrashekar L; Divyapriya D; Munisamy M; Revathy G
    J Am Acad Dermatol; 2017 May; 76(5):895-902. PubMed ID: 28089115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.
    Nishifuji K; Amagai M; Kuwana M; Iwasaki T; Nishikawa T
    J Invest Dermatol; 2000 Jan; 114(1):88-94. PubMed ID: 10620121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [How intravenous immunoglobulin therapy works in pemphigus].
    Aoyama Y
    Nihon Rinsho; 2012 Aug; 70(8):1437-43. PubMed ID: 22894086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens.
    Korang K; Ghohestani R; Krieg T; Uitto J; Hunzelmann N
    Acta Derm Venereol; 2002; 82(6):482-3. PubMed ID: 12575868
    [No Abstract]   [Full Text] [Related]  

  • 45. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.
    Waschke J; Bruggeman P; Baumgartner W; Zillikens D; Drenckhahn D
    J Clin Invest; 2005 Nov; 115(11):3157-65. PubMed ID: 16211092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
    Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J
    J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus.
    Joly P; Gilbert D; Thomine E; Zitouni M; Ghohestani R; Delpech A; Lauret P; Tron F
    J Invest Dermatol; 1997 Apr; 108(4):469-75. PubMed ID: 9077476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.
    Bystryn JC; Jiao D
    Autoimmunity; 2006 Nov; 39(7):601-7. PubMed ID: 17101504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
    Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A
    J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives.
    Torzecka JD; Narbutt J; Sysa-Jedrzejowska A; Waszczykowska E; Lukamowicz J; Pas HH
    Med Sci Monit; 2003 Dec; 9(12):CR528-33. PubMed ID: 14646976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies.
    Inaoki M; Kodera M; Fujimoto A; Nousari HC; Anhalt GJ; Takehara K
    Br J Dermatol; 2001 Mar; 144(3):610-3. PubMed ID: 11260026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
    Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum autoantibody profiles of IgA, IgE and IgM in canine pemphigus foliaceus.
    Bizikova P; Olivry T; Mamo LB; Dunston SM
    Vet Dermatol; 2014 Oct; 25(5):471-e75. PubMed ID: 24975693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spectrum of autoantibodies other than anti-desmoglein in pemphigus patients.
    Mejri K; Abida O; Kallel-Sellami M; Haddouk S; Laadhar L; Zarraa IR; Ben Ayed M; Zitouni M; Mokni M; Lahmar H; Fezaa B; Turki H; Tron F; Masmoudi H; Makni S
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):774-81. PubMed ID: 21029209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of canine pemphigus foliaceus autoantigen by immunoblotting.
    Iwasaki T; Shimizu M; Obata H; Isaji M; Yanai T; Kitagawa H; Sasaki Y
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):1-10. PubMed ID: 9437821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies.
    Hacker-Foegen MK; Janson M; Amagai M; Fairley JA; Lin MS
    J Invest Dermatol; 2003 Dec; 121(6):1373-8. PubMed ID: 14675185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
    Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
    J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of immunological profile with phenotype and disease outcome in pemphigus.
    Herrero-González JE; Iranzo P; Benítez D; Lozano F; Herrero C; Mascaró JM
    Acta Derm Venereol; 2010 Jul; 90(4):401-5. PubMed ID: 20574606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.